Silicone emulsion-enhanced recovery of chlorinated solvents: batch and column studies.

T. Kwon,Jung-Seok Yang,K. Baek,Jae‐Young Lee,Ji-won Yang

DOI: https://doi.org/10.1016/J.JHAZMAT.2005.12.038

IF: 13.6

2006-08-25

Journal of Hazardous Materials

Abstract:

What problem does this paper attempt to address?

I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections

Ivona Pandrea,Kelsie Brooks,Rahul P Desai,Minali Tare,Jason M Brenchley,Cristian Apetrei

DOI: https://doi.org/10.3389/fimmu.2022.899559

2022-08-12

Abstract:The lumen of the gastrointestinal (GI) tract contains an incredibly diverse and extensive collection of microorganisms that can directly stimulate the immune system. There are significant data to demonstrate that the spatial localization of the microbiome can impact viral disease pathogenesis. Here we discuss recent studies that have investigated causes and consequences of GI tract pathologies in HIV, SIV, and SARS-CoV-2 infections with HIV and SIV initiating GI pathology from the basal side and SARS-CoV-2 from the luminal side. Both these infections result in alterations of the intestinal barrier, leading to microbial translocation, persistent inflammation, and T-cell immune activation. GI tract damage is one of the major contributors to multisystem inflammatory syndrome in SARS-CoV-2-infected individuals and to the incomplete immune restoration in HIV-infected subjects, even in those with robust viral control with antiretroviral therapy. While the causes of GI tract pathologies differ between these virus families, therapeutic interventions to reduce microbial translocation-induced inflammation and improve the integrity of the GI tract may improve the prognoses of infected individuals.
Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV

Aya Ishizaka,Michiko Koga,Taketoshi Mizutani,Seiya Yamayoshi,Kiyoko Iwatsuki-Horimoto,Eisuke Adachi,Yutaka Suzuki,Yoshihiro Kawaoka,Hiroshi Yotsuyanagi

DOI: https://doi.org/10.1186/s12866-023-03157-5

IF: 4.465

2024-01-05

BMC Microbiology

Abstract:People living with HIV (PLWH) with chronic inflammation may have an increasing risk for coronavirus disease 2019 (COVID-19) severity; however, the impact of their gut microbiota on COVID-19 is not fully elucidated. Here, we analyzed the temporal changes in the gut microbiota composition of hospitalized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected PLWH (PLWH-CoV) and their correlation with COVID-19 severity.

microbiology
Characterization of proinflammatory cytokines profile during acute SARS-CoV-2 infection in people with human immunodeficiency virus

Alitzel Anzurez,Lucky Runtuwene,Thao Thi Thu Dang,Kaori Nakayama-Hosoya,Michiko Koga,Yukihiro Yoshimura,Hiroaki Sasaki,Nobuyuki Miyata,Kazuhito Miyazaki,Yoshimasa Takahashi,Tadaki Suzuki,Hiroshi Yotsuyanagi,Natsuo Tachikawa,Tetsuro Matano,Ai Kawana-Tachikawa

DOI: https://doi.org/10.7883/yoken.JJID.2024.184

2024-06-28

Abstract:Persistent inflammation in chronic HIV infection may affect immune responses against SARS-CoV-2 infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were assessed in people with HIV (PWH) with effective cART. There were no significant differences in any of the tested cytokines between COVID-19 severity in PWH, while most of them were significantly higher in individuals with severe disease in HIV-uninfected individuals, suggesting that excess cytokines release by hyper-inflammatory responses does not occur in severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, especially between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that PWH are in an enhanced inflammatory state. Loss of the several inter-cytokine correlations were observed in in vitro LPS stimuli-driven cytokines production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially due to the underlying inflammatory state and/or impairment of innate immune cells.
Enhanced innate antiviral gene expression, IFN-α, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection

David Verhoeven,Michael D George,William Hu,Angeline T Dang,Zeljka Smit-McBride,Elizabeth Reay,Monica Macal,Anne Fenton,Sumathi Sankaran-Walters,Satya Dandekar

DOI: https://doi.org/10.4049/jimmunol.1302415

2014-04-01

Abstract:The mucosa that lines the respiratory and gastrointestinal (GI) tracts is an important portal of entry for pathogens and provides the first line of innate immune defense against infections. Although an abundance of memory CD4(+) T cells at mucosal sites render them highly susceptible to HIV infection, the gut and not the lung experiences severe and sustained CD4(+) T cell depletion and tissue disruption. We hypothesized that distinct immune responses in the lung and gut during the primary and chronic stages of viral infection contribute to these differences. Using the SIV model of AIDS, we performed a comparative analysis of the molecular and cellular characteristics of host responses in the gut and lung. Our findings showed that both mucosal compartments harbor similar percentages of memory CD4(+) T cells and displayed comparable cytokine (IL-2, IFN-γ, and TNF-α) responses to mitogenic stimulations prior to infection. However, despite similar viral replication and CD4(+) T cell depletion during primary SIV infection, CD4(+) T cell restoration kinetics in the lung and gut diverged during acute viral infection. The CD4(+) T cells rebounded or were preserved in the lung mucosa during chronic viral infection, which correlated with heightened induction of type I IFN signaling molecules and innate viral restriction factors. In contrast, the lack of CD4(+) T cell restoration in the gut was associated with dampened immune responses and diminished expression of viral restriction factors. Thus, unique immune mechanisms contribute to the differential response and protection of pulmonary versus GI mucosa and can be leveraged to enhance mucosal recovery.
The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2

Jack A Collora,Runxia Liu,Kristen Albrecht,Ya-Chi Ho

DOI: https://doi.org/10.1097/COH.0000000000000655

Abstract:Purpose of review: CD4 T cell loss is the hallmark of uncontrolled HIV-1 infection. Strikingly, CD4 T cell depletion is a strong indicator for disease severity in the recently emerged coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We reviewed recent single-cell immune profiling studies in HIV-1 infection and COVID-19 to provide critical insight in virus-induced immunopathogenesis. Recent findings: Cytokine dysregulation in HIV-1 leads to chronic inflammation, while severe SARS-CoV-2 infection induces cytokine release syndrome and increased mortality. HIV-1-specific CD4 T cells are dysfunctional, while SARS-CoV-2-specific CD4 T cells exhibit robust Th1 function and correlate with protective antibody responses. In HIV-1 infection, follicular helper T cells (TFH) are susceptible to HIV-1 infection and persist in immune-sanctuary sites in lymphoid tissues as an HIV-1 reservoir. In severe SARS-CoV-2 infection, TFH are absent in lymphoid tissues and are associated with diminished protective immunity. Advancement in HIV-1 DNA, RNA, and protein-based single-cell capture methods can overcome the rarity and heterogeneity of HIV-1-infected cells and identify mechanisms of HIV-1 persistence and clonal expansion dynamics. Summary: Single-cell immune profiling identifies a high-resolution picture of immune dysregulation in HIV-1 and SARS-CoV-2 infection and informs outcome prediction and therapeutic interventions.
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

Alexandra E Livanos,Divya Jha,Francesca Cossarini,Ana S Gonzalez-Reiche,Minami Tokuyama,Teresa Aydillo,Tommaso L Parigi,Mark S Ladinsky,Irene Ramos,Katie Dunleavy,Brian Lee,Rebekah E Dixon,Steven T Chen,Gustavo Martinez-Delgado,Satish Nagula,Emily A Bruce,Huaibin M Ko,Benjamin S Glicksberg,Girish Nadkarni,Elisabet Pujadas,Jason Reidy,Steven Naymagon,Ari Grinspan,Jawad Ahmad,Michael Tankelevich,Yaron Bram,Ronald Gordon,Keshav Sharma,Jane Houldsworth,Graham J Britton,Alice Chen-Liaw,Matthew P Spindler,Tamar Plitt,Pei Wang,Andrea Cerutti,Jeremiah J Faith,Jean-Frederic Colombel,Ephraim Kenigsberg,Carmen Argmann,Miriam Merad,Sacha Gnjatic,Noam Harpaz,Silvio Danese,Carlos Cordon-Cardo,Adeeb Rahman,Robert E Schwartz,Nikhil A Kumta,Alessio Aghemo,Pamela J Bjorkman,Francesca Petralia,Harm van Bakel,Adolfo Garcia-Sastre,Saurabh Mehandru,Alexandra E. Livanos,Ana S. Gonzalez-Reiche,Tommaso L. Parigi,Mark S. Ladinsky,Rebekah E. Dixon,Steven T. Chen,Emily A. Bruce,Huaibin M. Ko,Benjamin S. Glicksberg,Graham J. Britton,Matthew P. Spindler,Jeremiah J. Faith,Robert E. Schwartz,Nikhil A. Kumta,Pamela J. Bjorkman

DOI: https://doi.org/10.1053/j.gastro.2021.02.056

IF: 29.4

2021-06-01

Gastroenterology

Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS">Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its effect on pathogenesis, and clinical significance.</AbstractText>METHODS: <AbstractText Label="METHODS">Human intestinal biopsy tissues were obtained from patients with COVID-19 (n = 19) and uninfected control individuals (n = 10) for microscopic examination, cytometry by time of flight analyses, and RNA sequencing. Additionally, disease severity and mortality were examined in patients with and without GI symptoms in 2 large, independent cohorts of hospitalized patients in the United States (N = 634) and Europe (N = 287) using multivariate logistic regressions.</AbstractText>RESULTS: <AbstractText Label="RESULTS">COVID-19 case patients and control individuals in the biopsy cohort were comparable for age, sex, rates of hospitalization, and relevant comorbid conditions. SARS-CoV-2 was detected in small intestinal epithelial cells by immunofluorescence staining or electron microscopy in 15 of 17 patients studied. High-dimensional analyses of GI tissues showed low levels of inflammation, including down-regulation of key inflammatory genes including IFNG, CXCL8, CXCL2, and IL1B and reduced frequencies of proinflammatory dendritic cells compared with control individuals. Consistent with these findings, we found a significant reduction in disease severity and mortality in patients presenting with GI symptoms that was independent of sex, age, and comorbid illnesses and despite similar nasopharyngeal SARS-CoV-2 viral loads. Furthermore, there was reduced levels of key inflammatory proteins in circulation in patients with GI symptoms.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">These data highlight the absence of a proinflammatory response in the GI tract despite detection of SARS-CoV-2. In parallel, reduced mortality in patients with COVID-19 presenting with GI symptoms was observed. A potential role of the GI tract in attenuating SARS-CoV-2-associated inflammation needs to be further examined.</AbstractText>

gastroenterology & hepatology
The welfare state: a eugenic appraisal.

F. Crew

1954-07-01

Abstract:T has long been a cherished dream of mine that perhaps some day I might be thought worthy of being invited to deliver this Galton Lecture. This dream, I must confess, has always contained an element of anxiety, for I have ever doubted that my performance would be found worthy of the occasion. I have always looked for'ward to an opportunity such as this when I might publicly acknowledge my indebtedness to Francis Galton, pay homage to him and express my gratitude. He played a most important part not only in the development of a science but also in the creation of a climate of opinion which made possible, even inevitable, the institution of academic departments of genetics, with one of which I was connected for a quarter of a century. A great deal of the abundant joy that was mine during those years stems directly from Galton's thought and philosophy. I chose this particular topic for consideration for entirely selfish reasons. It is one concerning which I ought, in virtue of my present academic position, to have ideas and opinions. To make this appointment with you would, I thought, compel me to clarify such ideas and to formulate such opinions. My fear of your adverse criticism of these would compel me to examine them very carefully; so I could not but profit. Maybe I have profited, but now that I am here I find it necessary to crave your indulgence, for that which I have to offer seems very commonplace and hardly worth the offering. Moreover, it was only a year ago, on this very occasion, when that eminent sociologist, Professor Marshall, dealt very adequately indeed with certain of the most important aspects of this very subject. To what he then said I can add nothing. But the subject is so many-sided and can
The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection

Alexandra Melton,Lori A. Rowe,Toni Penney,Clara Krzykwa,Kelly Goff,Sarah E. Scheuermann,Hunter J. Melton,Kelsey Williams,Nadia Golden,Kristyn Moore Green,Brandon Smith,Kasi Russell-Lodrigue,Jason P. Dufour,Lara A. Doyle-Meyers,Faith Schiro,Pyone P. Aye,Jeffery D. Lifson,Brandon J. Beddingfield,Robert V. Blair,Rudolf P. Bohm,Jay K. Kolls,Jay Rappaport,James A. Hoxie,Nicholas J. Maness

DOI: https://doi.org/10.3390/v16071173

2024-07-22

Viruses

Abstract:The effects of immunodeficiency associated with chronic HIV infection on COVID-19 disease and viral persistence have not been directly addressed in a controlled setting. In this pilot study, we exposed two pigtail macaques (PTMs) chronically infected with SIVmac239, exhibiting from very low to no CD4 T cells across all compartments, to SARS-CoV-2. We monitored the disease progression, viral replication, and evolution, and compared these outcomes with SIV-naïve PTMs infected with SARS-CoV-2. No overt signs of COVID-19 disease were observed in either animal, and the SARS-CoV-2 viral kinetics and evolution in the SIVmac239 PTMs were indistinguishable from those in the SIV-naïve PTMs in all sampled mucosal sites. However, the single-cell RNA sequencing of bronchoalveolar lavage cells revealed an infiltration of functionally inert monocytes after SARS-CoV-2 infection. Critically, neither of the SIV-infected PTMs mounted detectable anti-SARS-CoV-2 T-cell responses nor anti-SARS-CoV-2 binding or neutralizing antibodies. Thus, HIV-induced immunodeficiency alone may not be sufficient to drive the emergence of novel viral variants but may remove the ability of infected individuals to mount adaptive immune responses against SARS-CoV-2.

virology
Gas gangrene infections of the small intestine, colon and rectum

C. Hitchcock,M. Bubrick

DOI: https://doi.org/10.1007/BF02590862

1976-03-01

Diseases of the Colon & Rectum

Abstract:
Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection

Osaretin E Asowata,Alveera Singh,Abigail Ngoepe,Nicholas Herbert,Rabiah Fardoos,Kavidha Reddy,Yenzekile Zungu,Faith Nene,Ntombifuthi Mthabela,Dirhona Ramjit,Farina Karim,Katya Govender,Thumbi Ndung'u,J Zachary Porterfield,John H Adamson,Fusi G Madela,Vukani T Manzini,Frank Anderson,Alasdair Leslie,Henrik N Kløverpris

DOI: https://doi.org/10.1172/jci.insight.146162

IF: 9.4958

2021-11-22

JCI Insight

Abstract:HIV infection in the human gastrointestinal (GI) tract is thought to be central to HIV progression, but knowledge of this interaction is primarily limited to cohorts within Westernized countries. Here, we present a large cohort recruited from high HIV endemic areas in South Africa and found that people living with HIV (PLWH) presented at a younger age for investigation in the GI clinic. We identified severe CD4+ T cell depletion in the GI tract, which was greater in the small intestine than in the large intestine and not correlated with years on antiretroviral treatment (ART) or plasma viremia. HIV-p24 staining showed persistent viral expression, particularly in the colon, despite full suppression of plasma viremia. Quantification of mucosal antiretroviral (ARV) drugs revealed no differences in drug penetration between the duodenum and colon. Plasma markers of gut barrier breakdown and immune activation were elevated irrespective of HIV, but peripheral T cell activation was inversely correlated with loss of gut CD4+ T cells in PLWH alone. T cell activation is a strong predictor of HIV progression and independent of plasma viral load, implying that the irreversible loss of GI CD4+ T cells is a key event in the HIV pathogenesis of PLWH in South Africa, yet the underlying mechanisms remain unknown.
A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections

Tony Pan,Guoshuai Cao,Erting Tang,Yu Zhao,Pablo Penaloza-MacMaster,Yun Fang,Jun Huang

DOI: https://doi.org/10.3389/fgene.2023.1105673

IF: 3.7

2023-03-14

Frontiers in Genetics

Abstract:Introduction: Within the inflammatory immune response to viral infection, the distribution and cell type-specific profiles of immune cell populations and the immune-mediated viral clearance pathways vary according to the specific virus. Uncovering the immunological similarities and differences between viral infections is critical to understanding disease progression and developing effective vaccines and therapies. Insight into COVID-19 disease progression has been bolstered by the integration of single-cell (sc)RNA-seq data from COVID-19 patients with data from related viruses to compare immune responses. Expanding this concept, we propose that a high-resolution, systematic comparison between immune cells from SARS-CoV-2 infection and an inflammatory infectious disease with a different pathophysiology will provide a more comprehensive picture of the viral clearance pathways that underscore immunological and clinical differences between infections. Methods: Using a novel consensus single-cell annotation method, we integrate previously published scRNA-seq data from 111,566 single PBMCs from 7 COVID-19, 10 HIV-1 + , and 3 healthy patients into a unified cellular atlas. We compare in detail the phenotypic features and regulatory pathways in the major immune cell clusters. Results: While immune cells in both COVID-19 and HIV-1 + cohorts show shared inflammation and disrupted mitochondrial function, COVID-19 patients exhibit stronger humoral immunity, broader IFN-I signaling, elevated Rho GTPase and mTOR pathway activity, and downregulated mitophagy. Discussion: Our results indicate that differential IFN-I signaling regulates the distinct immune responses in the two diseases, revealing insight into fundamental disease biology and potential therapeutic candidates.

genetics & heredity
SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance

Renata R Nascimento,Cristhyane C Aquino,José K Sousa,Kalinne L Gadelha,Aurilene G Cajado,Carolina S Schiebel,Sarah A Dooley,Paulo A Sousa,Jefferson A Rocha,Jand R Medeiros,Pedro C Magalhães,Daniele Maria-Ferreira,Marcelo B Gois,Roberto C P Lima-Junior,Deysi V T Wong,Aldo M Lima,Amy C Engevik,Lucas D Nicolau,Mariana L Vale

DOI: https://doi.org/10.1016/j.mucimm.2024.03.009

Abstract:Studies have reported the occurrence of gastrointestinal (GI) symptoms, primarily diarrhea, in COVID-19. However, the pathobiology regarding COVID-19 in the GI tract remains limited. This work aimed to evaluate SARS-CoV-2 Spike protein interaction with gut lumen in different experimental approaches. Here, we present a novel experimental model with the inoculation of viral protein in the murine jejunal lumen, in vitro approach with human enterocytes, and molecular docking analysis. Spike protein led to increased intestinal fluid accompanied by Cl- secretion, followed by intestinal edema, leukocyte infiltration, reduced glutathione levels, and increased cytokine levels [interleukin (IL)-6, tumor necrosis factor-α, IL-1β, IL-10], indicating inflammation. Additionally, the viral epitope caused disruption in the mucosal histoarchitecture with impairment in Paneth and goblet cells, including decreased lysozyme and mucin, respectively. Upregulation of toll-like receptor 2 and toll-like receptor 4 gene expression suggested potential activation of local innate immunity. Moreover, this experimental model exhibited reduced contractile responses in jejunal smooth muscle. In barrier function, there was a decrease in transepithelial electrical resistance and alterations in the expression of tight junction proteins in the murine jejunal epithelium. Additionally, paracellular intestinal permeability increased in human enterocytes. Finally, in silico data revealed that the Spike protein interacts with cystic fibrosis transmembrane conductance regulator (CFTR) and calcium-activated chloride conductance (CaCC), inferring its role in the secretory effect. Taken together, all the events observed point to gut impairment, affecting the mucosal barrier to the innermost layers, establishing a successful experimental model for studying COVID-19 in the GI context.
HIV-1 infection is associated with depletion of germinal center B cells and a decrease in IgA+ plasma cells in the GI tract

Francesca Cossarini,Joan Shang,Azra Krek,Zainab Al-taie,Ruixue Hou,Pablo Canales-Herrerias,Minami Tokuyama,Michael Tankelevich,Adam Tillowiz,Divya Jha,Alexandra Livanos,Louise Leyre,Mathieu Uzzan,Gustavo Martinez-Delgado,Matthew D Taylor,Keshav Sharma,Arno R Bourgonje,Michael Cruz,Giorgio Ioannou,Travis Dawson,Darwin D'souza,Seunghee Kim-Schulze,Akm Ahmed,Judith A Aberg,Benjamin K Chen,Sacha Gnjatic,Alexandros D Polydorides,Andrea Cerutti,Carmen Argmann,Ivan Vujkovic-Cvijin,Mayte Suarez-Farinas,Francesca Petralia,Jeremiah J Faith,Saurabh Mehandru

DOI: https://doi.org/10.1101/2024.05.17.590425

2024-10-17

Abstract:Gastrointestinal (GI) B cells and plasma cells (PCs), critical to mucosal homeostasis, play an important role in the host response to HIV-1 infection. Here, high resolution mapping of human B cells and PCs from colon and ileum during both viremic and suppressed HIV-1 infection identified a significant reduction in germinal center (GC) B cells and Follicular Dendritic Cells (FDCs) during HIV-1 viremia. Further, IgA+ PCs, the major cellular output of intestinal GCs were significantly reduced during viremic HIV-1 infection. PC-associated transcriptional perturbations, including type I interferon signaling persisted in antiretroviral therapy (ART) treated individuals, suggesting ongoing disruption of the intestinal immune milieu during ART. GI humoral immune perturbations associated with changes in intestinal microbiome composition and systemic inflammation. Herein, we highlight a key immune defect in the GI mucosa due to HIV-1 viremia, with major implications.

Immunology
Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon

Bram Verstockt,Sare Verstockt,Saeed Abdu Rahiman,Bo-Jun Ke,Kaline Arnauts,Isabelle Cleynen,João Sabino,Marc Ferrante,Gianluca Matteoli,Séverine Vermeire

DOI: https://doi.org/10.1093/ecco-jcc/jjaa185

2021-03-05

Abstract:Background: Patients with inflammatory bowel disease [IBD] are considered immunosuppressed, but do not seem more vulnerable for COVID-19. Nevertheless, intestinal inflammation has shown to be an important risk factor for SARS-CoV-2 infection and prognosis. Therefore, we investigated the role of intestinal inflammation on the viral intestinal entry mechanisms, including ACE2, in IBD. Methods: We collected inflamed and uninflamed mucosal biopsies from Crohn's disease [CD] [n = 193] and ulcerative colitis [UC] [n = 158] patients, and from 51 matched non-IBD controls for RNA sequencing, differential gene expression, and co-expression analysis. Organoids from UC patients were subjected to an inflammatory mix and processed for RNA sequencing. Transmural ileal biopsies were processed for single-cell [sc] sequencing. Publicly available colonic sc-RNA sequencing data, and microarrays from tissue pre/post anti-tumour necrosis factor [TNF] therapy, were analysed. Results: In inflamed CD ileum, ACE2 was significantly decreased compared with control ileum [p = 4.6E-07], whereas colonic ACE2 was higher in inflamed colon of CD/UC compared with control [p = 8.3E-03; p = 1.9E-03]. Sc-RNA sequencing confirmed this ACE2 dysregulation and exclusive epithelial ACE2 expression. Network analyses highlighted HNF4A as key regulator of ileal ACE2, and pro-inflammatory cytokines and interferon regulating factors regulated colonic ACE2. Inflammatory stimuli upregulated ACE2 in UC organoids [p = 1.7E-02], but not in non-IBD controls [p = 9.1E-01]. Anti-TNF therapy restored colonic ACE2 regulation in responders. Conclusions: Intestinal inflammation alters SARS-CoV-2 coreceptors in the intestine, with opposing dysregulations in ileum and colon. HNF4A, an IBD susceptibility gene, seems an important upstream regulator of ACE2 in ileum, whereas interferon signalling might dominate in colon.
Carotid endarterectomy prior to major abdominal aortic surgery.

J. Bechtel,C. Bartels,S. Hopstein,S. Horsch

2000-04-01

Abstract:BACKGROUND Major aortic surgery carries a high risk of stroke. Carotid artery occlusive disease (CAOD) has been identified as one of the contributing risk factors. Regarding the long-term prevention of stroke, carotid endartectomy (CEA) seems to be superior to the best medical treatment in patients with high-grade CAOD. However, the role of CEA prior to major aortic surgery has not been studied. METHODS DESIGN Prospective study, observational design. SUBJECTS AND SETTING 201 patients referred to a community hospital for major aortic surgery. INTERVENTION The patients were non-invasively screened by continuous-wave and duplex Doppler ultrasonography for the presence of CAOD. In 41 patients with angiographically confirmed high-grade CAOD, CEA was performed prior to major aortic surgery. MAIN OUTCOME MEASURE Combined mortality and major morbidity from CEA and abdominal aortic surgery. RESULTS There was no mortality or morbidity related to CEA. Total perioperative mortality related to major aortic reconstruction was 3.5%. No new perioperative focal neurologic deficits occurred except for one fatal stroke in a patient in whom CEA had been judged not to be indicated. CONCLUSIONS CEA can be performed safely prior to major aortic surgery resulting in excellent overall neurologic outcome in patients with high-grade CAOD. We propose that patients scheduled for major aortic surgery be screened for the presence of high-grade CAOD and that CEA be performed first, if indicated according to published guidelines.
Gastrointestinal germinal center B cell depletion and reduction in IgA + plasma cells in HIV-1 infection

Francesca Cossarini,Joan Shang,Azra Krek,Zainab Al-Taie,Ruixue Hou,Pablo Canales-Herrerias,Minami Tokuyama,Michael Tankelevich,Adam Tillowitz,Divya Jha,Alexandra E. Livanos,Louise Leyre,Mathieu Uzzan,Gustavo Martinez-Delgado,Matthew D. Taylor,Keshav Sharma,Arno R. Bourgonje,Michael Cruz,Giorgio Ioannou,Travis Dawson,Darwin D'Souza,Seunghee Kim-Schulze,Ahmed Akm,Judith A. Aberg,Benjamin K. Chen,Douglas S. Kwon,Sacha Gnjatic,Alexandros D. Polydorides,Andrea Cerutti,Carmen Argmann,Ivan Vujkovic-Cvijin,Mayte Suarez-Fariñas,Francesca Petralia,Jeremiah J. Faith,Saurabh Mehandru

DOI: https://doi.org/10.1126/sciimmunol.ado0090

IF: 30.63

2024-10-26

Science Immunology

Abstract:Gastrointestinal (GI) B cells and plasma cells (PCs) are critical to mucosal homeostasis and the host response to HIV-1 infection. Here, high-resolution mapping of human B cells and PCs sampled from the colon and ileum during both viremic and suppressed HIV-1 infection identified a reduction in germinal center (GC) B cells and follicular dendritic cells (FDCs) during HIV-1 viremia. Immunoglobulin A–positive (IgA + ) PCs are the major cellular output of intestinal GCs and were significantly reduced during viremic HIV-1 infection. PC-associated transcriptional perturbations, including type I interferon signaling, persisted in antiretroviral therapy (ART)–treated individuals, suggesting ongoing disruption of the intestinal immune milieu during ART. GI humoral immune perturbations were associated with changes in the intestinal microbiome composition and systemic inflammation. These findings highlight a key immune defect in the GI mucosa due to HIV-1 viremia.

immunology
Estimation of the angle of arrival and the angular spread of a diffuse source in azimuth and sight

H. Boujemaa

DOI: https://doi.org/10.1109/ISCCSP.2004.1296279

2004-09-27

Abstract:In this paper, we treat the problem of source localisation in the presence of angular spread in azimuth and sight. In such contexts, the performance of conventional localisation algorithms such as MUSIC [R. Schmidt, 1979] degrades since they are adapted to point sources. In this paper, we use covariance matching estimators (COMET) [O. Besson et al., July 2000], [T. Trump et al., April 1996] to estimate both the azimuth, the sight and their respective angular spread. The performance of the proposed algorithm is compared to a theoretical study, MUSIC and the Cramer-Rao bound (CRB).
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier

Kelsie Brooks,Christine E. Nelson,Cynthia Aguilar,Timothy N. Hoang,Alexandra M. Ortiz,Charlotte A. Langner,Debra S. Yee,Jacob K. Flynn,Sophia Vrba,Elizabeth Laidlaw,Kevin M. Vannella,Alison Grazioli,Kapil K. Saharia,Madeleine Purcell,Shreya Singireddy,Jocelyn Wu,Jason Stankiewicz,Daniel S. Chertow,Irini Sereti,Mirko Paiardini,Heather D. Hickman,Laura E. Via,Daniel L. Barber,Jason M. Brenchley

DOI: https://doi.org/10.1128/jvi.01288-24

IF: 6.549

2024-09-13

Journal of Virology

Abstract:ABSTRACT SARS-CoV-2 infects via the respiratory tract, but COVID-19 includes an array of non-respiratory symptoms, among them gastrointestinal (GI) manifestations such as vomiting and diarrhea. Here we investigated the GI pathology of SARS-CoV-2 infections in rhesus macaques and humans. Macaques experienced mild infection with USA-WA1/2020 and shed viral RNA in the respiratory tract and stool, including subgenomic RNA indicative of replication in the GI tract. Intestinal immune cell populations were disturbed, with significantly fewer proliferating (Ki67+) jejunal B cells in SARS-CoV-2-infected macaques than uninfected ones. Modest translocation of bacteria/bacterial antigen was observed across the colonic epithelium, with a corresponding significant increase in plasma soluble CD14 (sCD14) that may be induced by LPS. Human plasma demonstrated significant decreases in interleukin (IL)-6 and sCD14 upon recovery from COVID-19, suggesting resolution of inflammation and response to translocated bacteria. sCD14 significantly positively correlated with zonulin, an indicator of gut barrier integrity, and IL-6. These results demonstrate that GI perturbations such as microbial translocation can occur in even mild SARS-CoV-2 infections and may contribute to the COVID-19 inflammatory state. IMPORTANCE This study investigates gastrointestinal (GI) barrier disruption in SARS-CoV-2 infections and how it may contribute to disease. We observed bacteria or bacterial products crossing from the colon interior (the lumen) to the lamina propria during SARS-CoV-2 infection in macaques. Bacteria/bacterial products are tolerated in the lumen but may induce immune responses if they translocate to the lamina propria. We also observed a significant increase in soluble CD14, which is associated with an immune response to bacterial products. In addition, we observed that humans recovering from COVID-19 experienced a significant decrease in soluble CD14, as well as the inflammatory marker interleukin (IL)-6. IL-6 and sCD14 correlated significantly across macaque and human samples. These findings suggest that SARS-CoV-2 infection results in GI barrier disruption that permits microbial translocation and a corresponding immune response. These findings could aid in developing interventions to improve COVID-19 patient outcomes.

virology
Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation

Stephanie M. Dillon,Moriah J. Castleman,Daniel N. Frank,Gregory L. Austin,Sara Gianella,Andrew C. Cogswell,Alan L. Landay,Edward Barker,Cara C. Wilson,Landay, Alan L.,Frank, Daniel N.,Gianella, Sara,Wilson, Cara C.,Austin, Gregory L.,Cogswell, Andrew C.,Castleman, Moriah J.,Dillon, Stephanie M.,Barker, Edward

DOI: https://doi.org/10.1097/QAI.0000000000001523

2019-10-03

Journal of Acquired Immune Deficiency Syndromes

Abstract:Background:HIV-1 infection is associated with intestinal inflammation, changes in the enteric microbiota (dysbiosis), and intestinal epithelial cell damage. NKp44+ innate lymphoid cells (ILCs) play an important role in epithelial barrier maintenance through the production of interleukin (IL)-22 but also display functional plasticity and can produce inflammatory cytokines [eg, interferon gamma (IFNγ)] in response to cytokine milieu and stimulatory signals. The objective of this pilot study was to enumerate frequencies of IL-22 and IFNγ-expressing colonic NKp44+ ILCs during untreated, chronic HIV-1 infection. Setting:A cross-sectional study was performed to compare numbers of cytokine-expressing ILCs in colonic biopsies of untreated, chronic HIV-1 infected (n = 22), and uninfected (n = 10) study participants. Associations between cytokine+ ILC and previously established measures of virological, immunological, and microbiome indices were analyzed. Methods:Multicolor flow cytometry was used to measure the absolute number of colonic CD3−NKp44±CD56± ILCs expressing IL-22 or IFNγ after in vitro mitogenic stimulation. Results:Numbers of colonic NKp44+ ILCs that expressed IFNγ were significantly higher in HIV-1 infected versus uninfected persons and positively correlated with relative abundances of dysbiotic bacterial species in the Xanthomonadaceae and Prevotellaceae bacterial families and with colonic myeloid dendritic cell and T-cell activation. Conclusion:Higher numbers of inflammatory colonic ILCs during untreated chronic HIV-1 infection that associated with dysbiosis and colonic myeloid dendritic cell and T-cell activation suggest that inflammatory ILCs may contribute to gut mucosal inflammation and epithelial barrier breakdown, important features of HIV-1 mucosal pathogenesis.
High IL-1β and IL-18 Levels Associate with Gut Barrier Disruption and Monocyte Activation During Chronic SIV Infection with Long-Term Suppressive Antiretroviral Therapy

Siva Thirugnanam,Chenxiao Wang,Chen Zheng,Brooke Grasperge,Prasun K Datta,Jay Rappaport,Xuebin Qin,Namita Rout

DOI: https://doi.org/10.1101/2024.06.14.599106

2024-06-17

Abstract:HIV-induced persistent immune activation is a key mediator of inflammatory comorbidities such as cardiovascular disease (CVD) and neurocognitive disorders. While a preponderance of data indicate that gut barrier disruption and microbial translocation are drivers of chronic immune activation, the molecular mechanisms of this persistent inflammatory state remain poorly understood. Here, utilizing the nonhuman primate model of HIV infection with suppressive antiretroviral therapy (ART), we investigated activation of inflammasome pathways and their association with intestinal epithelial barrier disruption and CVD pathogenesis. Longitudinal blood samples obtained from rhesus macaques with chronic SIV infection and long-term suppressive ART were evaluated for biomarkers of intestinal epithelial barrier disruption (IEBD), inflammasome activation (IL-1β and IL-18), inflammatory cytokines, and triglyceride (TG) levels. Activated monocyte subpopulations and glycolytic potential were investigated in peripheral blood mononuclear cells (PBMCs). Higher plasma levels of IL-1β and IL-18 were observed following the hallmark increase in IEBD biomarkers, intestinal fatty acid-binding protein (IFABP) and LPS-binding pro-tein (LBP), during the chronic phase of treated SIV infection. Further, significant correlations of plasma IFABP levels with IL-1β and IL-18 were observed between 10-12 months of ART. Higher levels of sCD14, IL-6, and GM-CSF, among other inflammatory mediators, were also observed only during the long-term SIV+ART phase along with a trend of increase in frequencies of activated CD14+CD16+ intermediate monocyte subpopulations. Lastly, we found elevated levels of blood TG and higher glycolytic capacity in PBMCs of chronic SIV-infected macaques with long-term ART. The increase in circulating IL-18 and IL-1β following IEBD and their significant positive correlation with IFABP suggest a connection between gut barrier disruption and inflammasome activation during chronic SIV infection, despite viral suppression with ART. Additionally, the increase in markers of monocyte activation, along with elevated TG and enhanced glycolytic pathway activity, indicates metabolic remodeling that could accelerate CVD pathogenesis. Further research is needed to understand mechanisms by which gut dysfunction and inflammasome activation contribute to HIV-associated CVD and metabolic complications, enabling targeted interventions in people with HIV.

Immunology

Silicone emulsion-enhanced recovery of chlorinated solvents: batch and column studies.

I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV

Characterization of proinflammatory cytokines profile during acute SARS-CoV-2 infection in people with human immunodeficiency virus

Enhanced innate antiviral gene expression, IFN-α, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection

The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

The welfare state: a eugenic appraisal.

The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection

Gas gangrene infections of the small intestine, colon and rectum

Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection

A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections

SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance

HIV-1 infection is associated with depletion of germinal center B cells and a decrease in IgA+ plasma cells in the GI tract

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon

Carotid endarterectomy prior to major abdominal aortic surgery.

Gastrointestinal germinal center B cell depletion and reduction in IgA + plasma cells in HIV-1 infection

Estimation of the angle of arrival and the angular spread of a diffuse source in azimuth and sight

SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier

Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation

High IL-1β and IL-18 Levels Associate with Gut Barrier Disruption and Monocyte Activation During Chronic SIV Infection with Long-Term Suppressive Antiretroviral Therapy